AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

Crisaborole 20 Mg ;

12 registrations across 1 African market— 12 active

Markets with Crisaborole 20 Mg ;

Recent registrations

Brand / ProductMarketHolderStatusExpires
Staquis
Topical Ointment
🇪🇬EgyptPfizer Biopharmaceuticals Egypt LLCactive
Crisacan
Topical Ointment
🇪🇬EgyptHikma Pharmaceuticals industriesactive
Eczanogab
Topical Ointment
🇪🇬EgyptGlobal Advanced pharmaceuticals "GAP"active
Marcrisa
Topical Ointment
🇪🇬EgyptMarcyrl pharmaceutical industries - MPIactive
Borocris
Topical Ointment
🇪🇬EgyptMedizen pharmaceutical industries (Medizen)active
Staquis
Topical Ointment
🇪🇬EgyptPfizer Biopharmaceuticals Egypt LLCactive
Borocris
Topical Ointment
🇪🇬EgyptMedizen pharmaceutical industries (Medizen)active
Crisamoun
Topical Ointment
🇪🇬EgyptAmoun Pharmaceutical Companyactive
Crisacan
Topical Ointment
🇪🇬EgyptHikma Pharmaceuticals industriesactive
Eczanogab
Topical Ointment
🇪🇬EgyptGlobal Advanced pharmaceuticals "GAP"active
Marcrisa
Topical Ointment
🇪🇬EgyptMarcyrl pharmaceutical industries - MPIactive
Crisamoun
Topical Ointment
🇪🇬EgyptAmoun Pharmaceutical Companyactive

Crisaborole 20 Mg ; in Africa — Regulatory Overview

Crisaborole 20 Mg ; is registered across 1 African markets with 12 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Egypt. AfricaRegulatory refreshes this data daily from official government sources.

Of the 12 registrations, 12 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.